Filing Details

Accession Number:
0001382963-17-000085
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-18 15:39:37
Reporting Period:
2017-05-18
Filing Date:
2017-05-18
Accepted Time:
2017-05-18 15:39:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460702 Ritter Pharmaceuticals Inc RTTR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237556 W Matthew Foehr Ritter Pharmaceuticals, Inc.
1880 Century Park East, Suite 1000
Los Angeles, CA 90067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-18 18,000 $0.62 35,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct